Vella et al., 2012 - Google Patents
Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragmentsVella et al., 2012
View PDF- Document ID
- 6588718585143552508
- Author
- Vella L
- Cappai R
- Publication year
- Publication venue
- The FASEB Journal
External Links
Snippet
Alzheimer's disease (AD) is a neurodegenerative disorder of the central nervous system. The proteolytic processing of the amyloid precursor protein (APP) into the β‐amyloid (Aβ) peptide is a central event in AD. While the pathway that generates Aβ is well described …
- 108060000460 APP 0 title abstract description 146
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vella et al. | Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments | |
Ludewig et al. | Novel insights into the physiological function of the APP (gene) family and its proteolytic fragments in synaptic plasticity | |
Sikora et al. | Cellular senescence in brain aging | |
Bright et al. | Human secreted tau increases amyloid-beta production | |
Fanutza et al. | APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses | |
Amadoro et al. | Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration | |
Swanson et al. | Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction | |
Schilling et al. | APLP1 is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission | |
Origlia et al. | Aβ-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: The role of RAGE | |
Sotthibundhu et al. | Aβ1–42 stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor | |
Chaplot et al. | Secreted chaperones in neurodegeneration | |
Armato et al. | Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia | |
US10138286B2 (en) | Methods and compositions for inhibiting the effects of amyloid beta oligomers | |
Balducci et al. | The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice | |
Lee et al. | A potential therapeutic effect of saikosaponin C as a novel dual‐target anti‐Alzheimer agent | |
Cho et al. | TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β | |
US20100081613A1 (en) | Methods and compositions for enhancing memory | |
Lantz et al. | The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models | |
Afreen et al. | The formation of small aggregates contributes to the neurotoxic effects of tau45-230 | |
Demuth et al. | Deletion of p75NTR rescues the synaptic but not the inflammatory status in the brain of a mouse model for Alzheimer’s disease | |
Gulisano | A renewed vision for Amyloid beta and tau in Alzheimer s disease pathophysiology | |
Ferreira Rodrigues | Propagation of Tau pathology in Alzheimer disease | |
Jang et al. | RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in Alzheimer’s disease | |
Mohammadi | Investigation of the therapeutic potential of the neuroprotective prion protein N1-fragment in cellular and mouse models of Alzheimers and prion disease | |
Gühna et al. | Rapid astroglial stress response and elevation of endogenous BiP levels promote neuronal survival in hippocampal slice cultures |